Transradial Artery Access in Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction and

Matthew S Schoenfeld1, Ibrahim Kassas1, Binita Shah2

  • 1New York University School of Medicine, 530 First Avenue, HCC-14, New York, NY, 10016, USA.

Insights

Transradial access (TRA) for percutaneous coronary intervention (PCI) is safe and effective in ST-elevation myocardial infarction (STEMI) and cardiogenic shock (CS) patients. TRA reduces bleeding and mortality compared to transfemoral access (TFA).

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Access

Background:

  • Early revascularization is crucial for ST-elevation myocardial infarction (STEMI) with cardiogenic shock (CS).
  • Transradial artery access (TRA) for percutaneous coronary intervention (PCI) is increasingly used, showing promise in high-risk patients.
  • TRA offers potential benefits over transfemoral artery access (TFA), including reduced bleeding and mortality.

Purpose of the Study:

  • To review the literature comparing TRA and TFA for PCI in STEMI and CS patients.
  • To summarize the benefits of TRA regarding bleeding, complications, and mortality in these patient groups.
  • To discuss technical considerations and challenges associated with TRA in high-risk populations.

Main Methods:

  • Systematic review of existing literature, including randomized clinical trials and observational data.
  • Analysis of studies comparing TRA versus TFA for PCI in patients with STEMI and CS.
  • Evaluation of outcomes such as major bleeding events, peri-procedural complications, and all-cause mortality.

Main Results:

  • Randomized trials demonstrate TRA advantages over TFA in STEMI patients, including reduced major bleeding and mortality.
  • Observational data suggest similar benefits of TRA compared to TFA in CS patients, despite a lack of dedicated trials.
  • TRA is associated with fewer peri-procedural complications and improved survival in both STEMI and CS populations.

Conclusions:

  • Transradial access is a safe and effective strategy for PCI in STEMI and CS patients.
  • TRA offers significant advantages over TFA, particularly in reducing bleeding and mortality.
  • Further research may be warranted to confirm TRA benefits in CS through dedicated randomized trials.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
540
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
303
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
424
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
735
Freezing Point Depression and Boiling Point Elevation03:12

Freezing Point Depression and Boiling Point Elevation

Boiling Point Elevation
The boiling point of a liquid is the temperature at which its vapor pressure is equal to ambient atmospheric pressure. Since the vapor pressure of a solution is lowered due to the presence of nonvolatile solutes, it stands to reason that the solution’s boiling point will subsequently be increased. Vapor pressure increases with temperature, and so a solution will require a higher temperature than will pure solvent to achieve any given vapor pressure, including one...
40.7K